Evidence map›Paper›PMID 26032419›Full record

ArticleThe Journal of biological chemistry2015

Prostate Sphere-forming Stem Cells Are Derived from the P63-expressing Basal Compartment.

Yanqing Huang, Tomoaki Hamana, Junchen Liu, Cong Wang, Lei An, Pan You, Julia Y F Chang, Jianming Xu, Wallace L McKeehan, Fen Wang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Prostate Cancer Stem Cells: Biology and Treatment Implications.International journal of molecular sciences · 2023
    Review
  3. Prostate organogenesis.Development (Cambridge, England) · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Strategies to Prevent "Bad Luck" in Cancer.Journal of the National Cancer Institute · 2015
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Yanqing HuangCenter for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas 77030.
Tomoaki HamanaCenter for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas 77030.
Junchen LiuCenter for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas 77030.
Cong WangWenzhou Medical College, Wenzhou, 325030 Zhejiang, China.
Lei AnCenter for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas 77030.
Pan YouCenter for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas 77030; Xiamen Zhongshan Hospital, Xiamen, 361004 Fujian, China.
Julia Y F ChangCenter for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas 77030.
Jianming XuBaylor College of Medicine, Houston, Texas 77030.
Wallace L McKeehanCenter for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas 77030.
Fen WangCenter for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas 77030; Wenzhou Medical College, Wenzhou, 325030 Zhejiang, China; Department of Molecular and Cellular Medicine, College of Medicine, Texas A&M Health Science Center, College Station, Texas 77807. Electronic address: fwang@ibt.tamhsc.edu.
Texas A&M Health Science Center · USWenzhou Medical University · CNBaylor College of Medicine · US

Funding

Targeting Tumor Microenvironment-Induced Therapy Resistance in Prostate Cancer Bone MetastasisP50CA140388 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOGOTHETIS, CHRISTOPHER J., THOMPSON, TIMOTHY CHARLES · 2009 to 2022
$23.4M
TISSUE COACTIVATOR AND RECEPTOR EXPRESSION FINGERPRINTSP01DK059820 · NIDDK · INSTITUT DE GENETIQUE ET BIOLOGIE MOLECU · PI O'MALLEY, BERT W · 2001 to 2016
$23.1M
The Role of SRC-1 in Breast CancerR01CA112403 · NCI · BAYLOR COLLEGE OF MEDICINE · PI XU, JIANMING · 2006 to 2016
$2.9M
Receptor-specific signaling of FGFR in the prostateR01CA096824 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WANG, FEN · 2003 to 2013
$2.5M
NCOA6, A Novel Tumor Suppressor of Endometrial CancerR01CA193455 · NCI · BAYLOR COLLEGE OF MEDICINE · PI XU, JIANMING · 2016 to 2021
$1.9M
FRS2-mediated Signals in Prostatic Tumorigenesis and DevelopmentR56CA096824 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WANG, FEN · 2008 to 2008
$302k
Fibroblast Growth Factor Signaling in Odontogenic Epithelial Stem CellsR56DE023106 · NIDCR · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WANG, FEN · 2013 to 2013
$285k
NCI NIH HHS CA140388NCI NIH HHS CA96824NCI NIH HHS P50 CA140388NCI NIH HHS R01 CA096824NCI NIH HHS R01 CA112403NCI NIH HHS R01 CA193455NCI NIH HHS R56 CA096824NIDCR NIH HHS DE023106NIDCR NIH HHS R56 DE023106NIDDK NIH HHS P01 DK059820
6 · The paper itself

Abstract

Prostate stem cells (P-SCs) are capable of giving rise to all three lineages of prostate epithelial cells, including basal, luminal, and neuroendocrine cells. Multiple methods have been used to identify P-SCs in adult prostates. These include in vivo renal capsule implantation of a single epithelial cell with urogenital mesenchymal cells, in vitro prostasphere and organoid cultures, and lineage tracing with castration-resistant Nkx3.1 expression (CARN), in conjunction with expression of cell type-specific markers. Both organoid culture and CARN tracing show the existence of P-SCs in the luminal compartment. Although prostasphere cells predominantly express basal cell-specific cytokeratin and P63, the lineage of prostasphere-forming cells in the P-SC hierarchy remains to be determined. Using lineage tracing with P63(CreERT2), we show here that the sphere-forming P-SCs are P63-expressing cells and reside in the basal compartment. Therefore we designate them as basal P-SCs (P-bSCs). P-bSCs are capable of differentiating into AR(+) and CK18(+) organoid cells, but organoid cells cannot form spheres. We also report that prostaspheres contain quiescent stem cells. Therefore, the results show that P-bSCs represent stem cells that are early in the hierarchy of overall prostate tissue stem cells. Understanding the contribution of the two types of P-SCs to prostate development and prostate cancer stem cells and how to manipulate them may open new avenues for control of prostate cancer progression and relapse.

Indexed as

Adult Stem CellsAnimalsCell DifferentiationCells, CulturedEpithelial CellsHomeodomain ProteinsMaleMiceOrgan Culture TechniquesPhosphoproteinsProstateReceptors, G-Protein-CoupledSpheroids, CellularTrans-ActivatorsTranscription FactorsHomeodomain ProteinsLgr5 protein, mouseNkx3-1 protein, mousePhosphoproteinsReceptors, G-Protein-CoupledTrans-ActivatorsTranscription FactorsTrp63 protein, mousecell signalingfibroblast growth factor (FGF)fibroblast growth factor receptor (FGFR)prostatestem cells

Identifiers

PMID26032419
PMCPMC4505023
OpenAlexW1449619551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.